Mr. Gus Gazzard, MBBChir MA MD FRCOphth, is a London-based Consultant Ophthalmic Surgeon and leading researcher in eye care. His primary areas of expertise are cataracts, glaucoma and the medical, laser and surgical treatment of glaucoma (including small incision and complex cataract surgery). He trained at Cambridge University and UCL, joining Moorfields Eye Hospital in 2005 after a Research Fellowship in Singapore, where he ran clinical trials of glaucoma surgery. He is Chief Investigator of the 6 year £2m multi-centre LiGHT trial of SLT in the UK and the sister trial in China. He is currently training surgeons in the use of the Trabectome, iStent, Xen, InnFocus, CyPass and Hydrus shunts.

mr. gus gazzard photo
Mr. Gus Gazzard MBBChir MA MD FRCOphth


Mr. Gazzard is the author of this definitive review of the data on the main treatment for angle closure glaucoma. You can read more about his ground-breaking research here 

Mr. Gazzard has recently been appointed Director of the Glaucoma Service at Moorfields Eye Hospital in London.

Mr. Gazzard has been awarded the prestigious, competitively awarded “NHS National Bronze Merit Award”. These awards recognise NHS consultants who perform ‘over and above’ the standard expected of their role.

Mr. Gazzard is now one of only three surgeons performing the innovative Hydrus stent procedure in the UK. You can read more about the Hydrus procedure here or you can download a PDF about Hydrus here.

NICE (National Institute for Health and Care Excellence) have released a report on Trabecular stent bypass microsurgery for open-angle glaucoma. You can read the full, positive report here.